These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. DAP-kinase as a target for drug design in cancer and diseases associated with accelerated cell death. Bialik S; Kimchi A Semin Cancer Biol; 2004 Aug; 14(4):283-94. PubMed ID: 15219621 [TBL] [Abstract][Full Text] [Related]
4. The genetics of the p53 pathway, apoptosis and cancer therapy. Vazquez A; Bond EE; Levine AJ; Bond GL Nat Rev Drug Discov; 2008 Dec; 7(12):979-87. PubMed ID: 19043449 [TBL] [Abstract][Full Text] [Related]
5. Mitochondrial function as an emerging 'target of interest' for cancer treatment. Sausville EA Curr Opin Investig Drugs; 2009 Jun; 10(6):523-5. PubMed ID: 19513940 [No Abstract] [Full Text] [Related]
6. High-content assays in oncology drug discovery: opportunities and challenges. Mouchet EH; Simpson PB IDrugs; 2008 Jun; 11(6):422-7. PubMed ID: 18509783 [TBL] [Abstract][Full Text] [Related]
7. Directing cancer cells to self-destruct with pro-apoptotic receptor agonists. Ashkenazi A Nat Rev Drug Discov; 2008 Dec; 7(12):1001-12. PubMed ID: 18989337 [TBL] [Abstract][Full Text] [Related]
8. Modulation of apoptosis signaling for cancer therapy. Fulda S; Debatin KM Arch Immunol Ther Exp (Warsz); 2006; 54(3):173-5. PubMed ID: 16652217 [TBL] [Abstract][Full Text] [Related]
9. Targeted therapeutics and implications for pathologists. Geyer SJ; Johnson PC Am J Clin Pathol; 2002 Jul; 118(1):144; author reply 144. PubMed ID: 12109849 [No Abstract] [Full Text] [Related]
11. [Advances in studies on inhibitor of apoptosis proteins and cancer therapy]. Wang XH; Fu LW Yao Xue Xue Bao; 2006 Feb; 41(2):103-7. PubMed ID: 16671537 [No Abstract] [Full Text] [Related]
13. The convergence of cancer prevention and therapy in early-phase clinical drug development. Abbruzzese JL; Lippman SM Cancer Cell; 2004 Oct; 6(4):321-6. PubMed ID: 15488755 [TBL] [Abstract][Full Text] [Related]
14. Cancer robustness: tumour tactics. Kitano H Nature; 2003 Nov; 426(6963):125. PubMed ID: 14614483 [No Abstract] [Full Text] [Related]
15. Making sense of Rx. The SARS epidemic has refocused medical attention on a promising germ-fighting strategy. Hobson K US News World Rep; 2003 Jun; 134(20):60. PubMed ID: 12827982 [No Abstract] [Full Text] [Related]
16. Deal-making trends in oncology. Moore K; Walker J Nat Rev Drug Discov; 2009 Aug; 8(8):604. PubMed ID: 19644466 [No Abstract] [Full Text] [Related]
17. Reasons to reconsider the significance of apoptosis for cancer therapy. Abend M Int J Radiat Biol; 2003 Dec; 79(12):927-41. PubMed ID: 14713571 [TBL] [Abstract][Full Text] [Related]
18. Molecular imaging as a tool for personalized and targeted anticancer therapy. McLarty K; Reilly RM Clin Pharmacol Ther; 2007 Mar; 81(3):420-4. PubMed ID: 17339871 [No Abstract] [Full Text] [Related]
19. Targeted therapies: aiming for the bull's-eye. Gaguski ME ONS Connect; 2007 Jul; 22(7):8-12. PubMed ID: 17694778 [No Abstract] [Full Text] [Related]
20. New targets for cancer chemotherapy. Murgo AJ; Dancey J; Eckhardt SG; Hidalgo M; Arbuck SG; Zerivitz K; Blaylock BA Cancer Chemother Biol Response Modif; 2002; 20():239-72. PubMed ID: 12703208 [No Abstract] [Full Text] [Related] [Next] [New Search]